Skip to main content

Not investment advice.Read full disclaimer

Healthcare · Biotechnology

52W Range

1thpctl

Volume

0.11×avg

Market Cap

31.62MUSD

P/E Ratio

-0.6TTM

Div Yield

-ann

Continue with finqOS

Explore Aligos Therapeutics, Inc.'s financials

Income statements, balance sheets, and cash flows - annual and quarterly, going back 20+ years.

Start Free Trial→Sign In

14-day free trial · No credit card required

Aligos Therapeutics, Inc.

ALGSNASDAQ Global Select·USD·Closed

Aligos Therapeutics, Inc.

ALGSNASDAQ·USD·Closed

$5.11

−4.31%

$5.11

−$0.23 (4.31%)

52W Range

1thpctl

Volume

0.11×avg

Mkt Cap

31.62MUSD

P/E

-0.6TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

ALGS: Aligos Therapeutics, Inc. Financial Statements & Revenue | finqOS